Nanomedicine News

RSS
Customizing Nanoparticles to Target Tumors, Viruses and Toxins

Customizing Nanoparticles to Target Tumors, Viruses and Toxins

AI-Nanopore Platform Enables Precise COVID-19 Screening

AI-Nanopore Platform Enables Precise COVID-19 Screening

Deep Learning Tackles Nanoparticle Shape Identification Challenges

Deep Learning Tackles Nanoparticle Shape Identification Challenges

Discovering New Ways to Boost Nanoparticle Delivery to Tumors

Discovering New Ways to Boost Nanoparticle Delivery to Tumors

Experimental Vaccine Uses Nanoparticles to Target Protein Key to Cancer Spread

Experimental Vaccine Uses Nanoparticles to Target Protein Key to Cancer Spread

NanoSABER Probes Illuminate New Horizons in Cancer Imaging

NanoSABER Probes Illuminate New Horizons in Cancer Imaging

Nanocapsule Helps Boost the Activity of Mice Immune Cells

Nanocapsule Helps Boost the Activity of Mice Immune Cells

Developing an Ultrasensitive Method for Detecting Nanoscale Extracellular Vesicles

Developing an Ultrasensitive Method for Detecting Nanoscale Extracellular Vesicles

Nanotechnology Designs with Minimal Negative Effects for Intravenous Injections

Nanotechnology Designs with Minimal Negative Effects for Intravenous Injections

New Theory Explains How Nanoparticles Enter and Exit the Tumors

New Theory Explains How Nanoparticles Enter and Exit the Tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.